IL5 and non-small cell lung carcinoma: Intriguingly, the expression of IL5 and IL9 was increased in ILC2s from PBMCs from NSCLC patients, but not in ILC2s from tumor tissues, compared with HD-derived PBMCs (Supplementary Figure 2B).